Lord, Abbett & Co’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-483,997
| Closed | -$50.1M | – | 656 |
|
|
2021
Q4 | $50.1M | Sell |
483,997
-746,092
| -61% | -$86.4M | 0.11% | 261 |
|
|
2021
Q3 | $154M | Sell |
1,230,089
-54,332
| -4% | -$7.03M | 0.37% | 70 |
|
|
2021
Q2 | $159M | Buy |
1,284,421
+155,832
| +14% | +$19.6M | 0.38% | 63 |
|
|
2021
Q1 | $133M | Sell |
1,128,589
-59,343
| -5% | -$6.96M | 0.34% | 77 |
|
|
2020
Q4 | $139M | Sell |
1,187,932
-52,255
| -4% | -$5.75M | 0.37% | 74 |
|
|
2020
Q3 | $129M | Sell |
1,240,187
-543,620
| -30% | -$54.6M | 0.41% | 57 |
|
|
2020
Q2 | $164M | Sell |
1,783,807
-245,222
| -12% | -$23.5M | 0.57% | 24 |
|
|
2020
Q1 | $183M | Buy |
2,029,029
+154,757
| +8% | +$16.5M | 0.81% | 8 |
|
|
2019
Q4 | $213M | Sell |
1,874,272
-123,510
| -6% | -$13.6M | 0.71% | 13 |
|
|
2019
Q3 | $217M | Sell |
1,997,782
-334,396
| -14% | -$34.9M | 0.74% | 9 |
|
|
2019
Q2 | $227M | Buy |
2,332,178
+644,084
| +38% | +$58.8M | 0.74% | 5 |
|
|
2019
Q1 | $154M | Sell |
1,688,094
-72,700
| -4% | -$6.51M | 0.51% | 24 |
|
|
2018
Q4 | $160M | Buy |
1,760,794
+320,000
| +22% | +$29.9M | 0.58% | 22 |
|
|
2018
Q3 | $142M | Sell |
1,440,794
-26,800
| -2% | -$2.48M | 0.39% | 42 |
|
|
2018
Q2 | $126M | Sell |
1,467,594
-32,100
| -2% | -$2.68M | 0.37% | 37 |
|
|
2018
Q1 | $120M | Buy |
1,499,694
+29,700
| +2% | +$2.45M | 0.36% | 49 |
|
|
2017
Q4 | $119M | Sell |
1,469,994
-50,300
| -3% | -$4.03M | 0.34% | 61 |
|
|
2017
Q3 | $118M | Buy |
1,520,294
+83,800
| +6% | +$6.96M | 0.35% | 55 |
|
|
2017
Q2 | $127M | Buy |
1,436,494
+16,500
| +1% | +$1.39M | 0.38% | 51 |
|
|
2017
Q1 | $114M | Buy |
1,419,994
+80,200
| +6% | +$6.26M | 0.34% | 64 |
|
|
2016
Q4 | $95.4M | Sell |
1,339,794
-62,000
| -4% | -$4.87M | 0.29% | 91 |
|
|
2016
Q3 | $121M | Sell |
1,401,794
-57,100
| -4% | -$4.98M | 0.37% | 47 |
|
|
2016
Q2 | $127M | Buy |
1,458,894
+235,100
| +19% | +$19M | 0.4% | 40 |
|
|
2016
Q1 | $91.8M | Buy |
1,223,794
+190,000
| +18% | +$14.3M | 0.29% | 81 |
|
|
2015
Q4 | $79.5M | Sell |
1,033,794
-229,400
| -18% | -$17.3M | 0.24% | 105 |
|
|
2015
Q3 | $84.6M | Buy |
1,263,194
+530,100
| +72% | +$39M | 0.26% | 101 |
|
|
2015
Q2 | $54.3M | Sell |
733,094
-601,600
| -45% | -$46M | 0.14% | 217 |
|
|
2015
Q1 | $104M | Buy |
1,334,694
+284,800
| +27% | +$21.6M | 0.26% | 89 |
|
|
2014
Q4 | $75.8M | Buy |
1,049,894
+391,942
| +60% | +$27.2M | 0.19% | 134 |
|
|
2014
Q3 | $40.8M | Buy |
657,952
+159,387
| +32% | +$10.1M | 0.1% | 278 |
|
|
2014
Q2 | $31.8M | Sell |
498,565
-4,523
| -0.9% | -$275K | 0.07% | 401 |
|
|
2014
Q1 | $31M | Sell |
503,088
-271,516
| -35% | -$15.8M | 0.07% | 400 |
|
|
2013
Q4 | $44.5M | Sell |
774,604
-124,181
| -14% | -$7.04M | 0.1% | 301 |
|
|
2013
Q3 | $47.9M | Sell |
898,785
-1,589,731
| -64% | -$85.5M | 0.11% | 266 |
|
|
2013
Q2 | $128M | Buy |
+2,488,516
| New | +$123M | 0.3% | 78 |
|
Other funds holding MDT
WA
Lord, Abbett & Co's MDT Position: Q1 2022 in Review
Lord, Abbett & Co sold out of Medtronic (MDT) in Q1 2022, closing a stake of 483,997 shares — an estimated $50.1M sold.
Lord, Abbett & Co first reported a position in MDT in Q2 2013 and held it in 35 quarters. The position peaked at $227M in Q2 2019. 2,101 funds tracked by Wall St. Rank hold MDT as of Q1 2022.
- Lord, Abbett & Co reported no remaining Medtronic position as of Q1 2022 after selling out during the quarter.
- Lord, Abbett & Co sold 483,997 Medtronic shares in Q1 2022, an estimated $50.1M.
- Lord, Abbett & Co first reported a position in Medtronic in Q2 2013 and held it in 35 quarters.
- Lord, Abbett & Co's Medtronic position peaked at $227M in Q2 2019.
- 2,101 funds tracked by Wall St. Rank held Medtronic as of Q1 2022.
Based on Lord, Abbett & Co's 13F filing for Q1 2022, filed 13 May 2022.